Board of Directors

hero-overlay

Tim Wilson, PhD.

Chief Executive Officer

Tim’s career in the life sciences has encompassed start ups, venture capital, investment banking and equity research. He has held senior positions at a number of firms including

About

Pete Finan

Non-Executive Chairman

Pete joined Epidarex Capital as a Venture Partner in 2014. He has more than twenty years of experience in drug discovery within the pharmaceutical industry. Prior to joining

About
Marianne Uteng - Board member of Epsilogen

Marianne Uteng

Board Member

Marianne Uteng PhD is a Managing Director at NVF in Basel, Switzerland. Prior to that, she worked in Novartis Global Drug Development, and in the Pre-Clinical Safety Department

About

Marianne Bjørdal

Board Member

Marianne is a Partner at 3B Future Health Ventures, advisor to a venture capital fund investing in early-stage companies developing novel technologies and new treatments in oncology and

About

Alek Safarian

Board Member

Alek Safarian is the CEO of venture investment firm, ALSA Holdings Ltd. Alek has a diverse background in drug development spanning some 30 years. Trained as a pharmacist,

About

Emma Johnson

Board Member

Emma is a Senior Investment Manager in the British Patient Capital Direct Investments team, where she focuses on opportunities in the life sciences. Emma joined the BPC team

About